Craig-Hallum Maintains Cellebrite(CLBT.US) With Buy Rating, Announces Target Price $23
Cellebrite DI (CLBT) Gets a Buy From Craig-Hallum
Cellebrite Patents Its Remote Mobile Collection Capabilities for Businesses
Cellebrite DI Is Maintained at Buy by TD Cowen
TD Cowen Maintains Cellebrite(CLBT.US) With Buy Rating, Raises Target Price to $23
TD Cowen analyst Shaul Eyal maintains $Cellebrite(CLBT.US)$ with a buy rating, and adjusts the target price from $15 to $23.According to TipRanks data, the analyst has a success rate of 69.6% and a
Express News | Cellebrite DI Ltd : TD Cowen Raises Target Price to $23 From $20